Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS Coronavirus (SARS-CoV-2) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05046652
What this trial is testing

Effectiveness of Convalescent Plasma Therapy in 8 Non-Intubated COVID-19 Patients in Indonesia: A Case Series

Who this might be right for
Infectious Disease
Maranatha Christian University 8
Not applicableStudy completedNCT04841785
What this trial is testing

RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients

Who this might be right for
Covid19SARS-CoV InfectionChronic Kidney Diseases
University Medical Center Groningen 4,868
Not applicableUnknownNCT05125913
What this trial is testing

Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2

Who this might be right for
CKDDialysisKidney Transplant+3 more
Grigore T. Popa University of Medicine and Pharmacy 250
Testing effectiveness (Phase 2)UnknownNCT04356482
What this trial is testing

CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19

Who this might be right for
COVID-19SARS-CoV 2Convalescence+2 more
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado 90
Testing effectiveness (Phase 2)Ended earlyNCT04969991
What this trial is testing

Study of Varespladib in Patients Hospitalized With Severe COVID-19

Who this might be right for
Coronavirus Disease 2019Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
Ophirex, Inc. 18
Not applicableLooking for participantsNCT04706390
What this trial is testing

Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination

Who this might be right for
Covid19
University of Bergen 2,500
Testing effectiveness (Phase 2)Study completedNCT05605470
What this trial is testing

Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults

Who this might be right for
COVID-19, SARS CoV 2 Infection
Technovalia, Pty Ltd 150
Large-scale testing (Phase 3)UnknownNCT06068569
What this trial is testing

Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 50
Testing effectiveness (Phase 2)Study completedNCT04671017
What this trial is testing

Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects

Who this might be right for
SARS-CoV-2 Virus Infection
Valneva Austria GmbH 153
Not applicableUnknownNCT05125874
What this trial is testing

Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 45
Not applicableStudy completedNCT04380727
What this trial is testing

Almitrine and COVID-19 Related Hypoxemia

Who this might be right for
COVID-19Hypoxic Respiratory Failure
Central Hospital, Nancy, France 17
Not applicableUnknownNCT04449627
What this trial is testing

Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Naturalistic Cohort Study With a Digital Intervention

Who this might be right for
Anxiety DisordersPost Traumatic Stress DisorderDepressive Disorder+1 more
Royal Free Hospital NHS Foundation Trust 125
Testing effectiveness (Phase 2)Study completedNCT04608305
What this trial is testing

Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine

Who this might be right for
Covid19
Israel Institute for Biological Research (IIBR) 843
Not applicableStudy completedNCT04673279
What this trial is testing

Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina

Who this might be right for
Coronavirus Disease 2019
Hospital Italiano de Buenos Aires 189
Large-scale testing (Phase 3)Temporarily pausedNCT04341870
What this trial is testing

Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO

Who this might be right for
COVID19SARS-CoV-2 Infection
Assistance Publique - Hôpitaux de Paris 27
Not applicableStudy completedNCT06191341
What this trial is testing

Consequences in ICU of Vaccination Status of Covid-19 Patients

Who this might be right for
SARS CoV 2 Infection
Centre Hospitalier Régional Metz-Thionville 1,058
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more
PEACHES BIOTECH 50
Not applicableWithdrawnNCT04351490
What this trial is testing

Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19

Who this might be right for
SARS-CoV 2
University Hospital, Lille
Not applicableLooking for participantsNCT05638724
What this trial is testing

Munich Long COVID Registry for Children, Adolescents, and Adults

Who this might be right for
Post-COVID Condition
Technical University of Munich 1,000
Large-scale testing (Phase 3)Study completedNCT04655625
What this trial is testing

Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)

Who this might be right for
COVID-19
AnGes, Inc. 500
Next Page